Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease.
Leffler
Daniel
D
Cloud
Jeffery W
JW
Kelly
Ciaran P
CP
D000900:Anti-Bacterial Agents; D016360:Clostridioides difficile; D017714:Community-Acquired Infections / Q000453:epidemiology; D015897:Comorbidity; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis / Q000453:epidemiology*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006635:Histamine H2 Antagonists / Q000009:adverse effects; D006801:Humans; D054328:Proton Pump Inhibitors; D012306:Risk
D000900:Anti-Bacterial Agents; D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors